The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Zoonotic Disease Treatment Market Research Report 2024
Synopsis
Zoonotic Disease is directly transmitted from animals to humans through media such as air (influenza) or through bites and saliva (rabies).
The global Zoonotic Disease Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 21%.
This report aims to provide a comprehensive presentation of the global market for Zoonotic Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zoonotic Disease Treatment.
Report Scope
The Zoonotic Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Zoonotic Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zoonotic Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Novartis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Roche
AstraZeneca
BioCryst
AstraZeneca
Segment by Type
Viral Hepatitis
Rabies
Relapsing Fever
Tuberculosis
Malaria
Others
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Zoonotic Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Zoonotic Disease is directly transmitted from animals to humans through media such as air (influenza) or through bites and saliva (rabies).
The global Zoonotic Disease Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 21%.
This report aims to provide a comprehensive presentation of the global market for Zoonotic Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zoonotic Disease Treatment.
Report Scope
The Zoonotic Disease Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Zoonotic Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zoonotic Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Novartis
Pfizer
Johnson & Johnson
GlaxoSmithKline
Roche
AstraZeneca
BioCryst
AstraZeneca
Segment by Type
Viral Hepatitis
Rabies
Relapsing Fever
Tuberculosis
Malaria
Others
Segment by Application
Hospitals
Clinics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Zoonotic Disease Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Zoonotic Disease Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Viral Hepatitis
1.2.3 Rabies
1.2.4 Relapsing Fever
1.2.5 Tuberculosis
1.2.6 Malaria
1.2.7 Others
1.3 Market by Application
1.3.1 Global Zoonotic Disease Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Zoonotic Disease Treatment Market Perspective (2019-2030)
2.2 Zoonotic Disease Treatment Growth Trends by Region
2.2.1 Global Zoonotic Disease Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Zoonotic Disease Treatment Historic Market Size by Region (2019-2024)
2.2.3 Zoonotic Disease Treatment Forecasted Market Size by Region (2025-2030)
2.3 Zoonotic Disease Treatment Market Dynamics
2.3.1 Zoonotic Disease Treatment Industry Trends
2.3.2 Zoonotic Disease Treatment Market Drivers
2.3.3 Zoonotic Disease Treatment Market Challenges
2.3.4 Zoonotic Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Zoonotic Disease Treatment Players by Revenue
3.1.1 Global Top Zoonotic Disease Treatment Players by Revenue (2019-2024)
3.1.2 Global Zoonotic Disease Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Zoonotic Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Zoonotic Disease Treatment Revenue
3.4 Global Zoonotic Disease Treatment Market Concentration Ratio
3.4.1 Global Zoonotic Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Zoonotic Disease Treatment Revenue in 2023
3.5 Zoonotic Disease Treatment Key Players Head office and Area Served
3.6 Key Players Zoonotic Disease Treatment Product Solution and Service
3.7 Date of Enter into Zoonotic Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Zoonotic Disease Treatment Breakdown Data by Type
4.1 Global Zoonotic Disease Treatment Historic Market Size by Type (2019-2024)
4.2 Global Zoonotic Disease Treatment Forecasted Market Size by Type (2025-2030)
5 Zoonotic Disease Treatment Breakdown Data by Application
5.1 Global Zoonotic Disease Treatment Historic Market Size by Application (2019-2024)
5.2 Global Zoonotic Disease Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Zoonotic Disease Treatment Market Size (2019-2030)
6.2 North America Zoonotic Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Zoonotic Disease Treatment Market Size by Country (2019-2024)
6.4 North America Zoonotic Disease Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Zoonotic Disease Treatment Market Size (2019-2030)
7.2 Europe Zoonotic Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Zoonotic Disease Treatment Market Size by Country (2019-2024)
7.4 Europe Zoonotic Disease Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Zoonotic Disease Treatment Market Size (2019-2030)
8.2 Asia-Pacific Zoonotic Disease Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Zoonotic Disease Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Zoonotic Disease Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Zoonotic Disease Treatment Market Size (2019-2030)
9.2 Latin America Zoonotic Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Zoonotic Disease Treatment Market Size by Country (2019-2024)
9.4 Latin America Zoonotic Disease Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Zoonotic Disease Treatment Market Size (2019-2030)
10.2 Middle East & Africa Zoonotic Disease Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Zoonotic Disease Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Zoonotic Disease Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Zoonotic Disease Treatment Introduction
11.1.4 Sanofi Revenue in Zoonotic Disease Treatment Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Zoonotic Disease Treatment Introduction
11.2.4 Novartis Revenue in Zoonotic Disease Treatment Business (2019-2024)
11.2.5 Novartis Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Zoonotic Disease Treatment Introduction
11.3.4 Pfizer Revenue in Zoonotic Disease Treatment Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Zoonotic Disease Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Zoonotic Disease Treatment Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Detail
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Zoonotic Disease Treatment Introduction
11.5.4 GlaxoSmithKline Revenue in Zoonotic Disease Treatment Business (2019-2024)
11.5.5 GlaxoSmithKline Recent Development
11.6 Roche
11.6.1 Roche Company Detail
11.6.2 Roche Business Overview
11.6.3 Roche Zoonotic Disease Treatment Introduction
11.6.4 Roche Revenue in Zoonotic Disease Treatment Business (2019-2024)
11.6.5 Roche Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Zoonotic Disease Treatment Introduction
11.7.4 AstraZeneca Revenue in Zoonotic Disease Treatment Business (2019-2024)
11.7.5 AstraZeneca Recent Development
11.8 BioCryst
11.8.1 BioCryst Company Detail
11.8.2 BioCryst Business Overview
11.8.3 BioCryst Zoonotic Disease Treatment Introduction
11.8.4 BioCryst Revenue in Zoonotic Disease Treatment Business (2019-2024)
11.8.5 BioCryst Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Detail
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Zoonotic Disease Treatment Introduction
11.9.4 AstraZeneca Revenue in Zoonotic Disease Treatment Business (2019-2024)
11.9.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
